ASPIRIN CARDIO

Country: Malasja

Lingwa: Ingliż

Sors: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Ingredjent attiv:

Acetylsalicylic Acid

Disponibbli minn:

BAYER CO. (MALAYSIA) SDN. BHD.

INN (Isem Internazzjonali):

Acetylsalicylic Acid

Unitajiet fil-pakkett:

20Tablet Tablets; 50Tablet Tablets; 100Tablet Tablets; 30 Tablet Tablets; 240 Tablet Tablets

Manifatturat minn:

BAYER AG

Fuljett ta 'informazzjoni

ASPIRIN_®_ CARDIO TABLET_ _
Acetylsalicylic acid (100mg)
1
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1.
What
_Aspirin Cardio_
is used for
2.
How
_Aspirin Cardio_
works
3.
Before you use
_Aspirin Cardio_
4.
How to use
_Aspirin Cardio_
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of
_Aspirin _
_Cardio_
8.
Product Description
9.
Manufacturer and Product
Registration Holder
10.
Date of revision
WHAT _ASPIRIN CARDIO_ IS USED FOR
Prevention of blood clots in high risk
people especially those who had heart
attack,
stroke,
unstable
angina
(chest
pain) and bypass surgery.
Note: Aspirin Cardio is not suitable for
the treatment of pain.
HOW _ASPIRIN CARDIO_ WORKS
Aspirin Cardio inhibits the adhesion and
clumping of blood platelets and in this
way prevents blood clots from
developing.
BEFORE YOU USE _ASPIRIN CARDIO _
_- When you must not use it _
Do not take
_Aspirin Cardio_
-
if you are allergic to acetylsalicylic
acid, salicylates or any of the other
ingredients of Aspirin Cardio listed
at the end of the leaflet;
-
if you have a history of reacting to
certain medicines against pain, fever
or inflammation (salicylates or other
nonsteroidal anti-inflammatory
drugs)
-
if you have acute gastric or duodenal
ulcers;
-
if you have increased tendency to
bleed
-
if you have liver or kidney failure;
-
if you have severe heart failure for
which you are not receiving
adequate treatment;
-
if you are concurrently taking 15 mg
or more methotrexate per week;
-
in the last trimester of pregnancy at
dosages above 100 mg
acetylsalicylic acid/day (see
“Pregnancy and breast feeding”).
_- Before you start to use it _
Inform your doctor if you
-
have asthma, or suffer from any
allergies
-
have a history of gastrointestinal
bleeding;
-
have impaired heart and blood
circulation
-
will have surgery (including minor
surgery such as dental extractions):
increase in bleeding tendency can
occur.
-
are suffering from severe glucose-6-
phosphate dehydrogenase (G6PD)
deficiency
If you cut or injur

Karatteristiċi tal-prodott

Date of text revision: 10
th
February 2023
Reference: Aspirin Cardio / 81, 100, 300, 325 mg / tablets, chewable
tablets, gastro-resistant tablets / CCDS /
Version 10 / 27 Oct 2022
1
INSTRUCTIONS FOR USE. INFORMATION FOR THE PATIENT
ASPIRIN® CARDIO
Enteric-coated tablets with 100 mg acetylsalicylic acid
PLEASE READ THE ENTIRE PATIENT INFORMATION LEAFLET CAREFULLY AS IT
CONTAINS
IMPORTANT INFORMATION ON USING THE MEDICINE.
This medicine is available on a non-prescription basis. To achieve the
best possible
therapeutic results, you must nonetheless use Aspirin Cardio as
directed.
-
Keep the patient information leaflet – you may wish to read it again
later.
-
If you have any further questions or need advice, please consult your
pharmacist.
-
If your condition worsens or has not improved, in any case you must
consult a
doctor.
This patient information leaflet concerns the following:
1.
What is Aspirin Cardio and what is it used for?
2.
What should you be aware of before taking Aspirin Cardio?
3.
How should Aspirin Cardio be taken?
4.
What side effects may occur?
5.
How should Aspirin Cardio be stored?
6.
Further information
1.
WHAT IS ASPIRIN CARDIO AND WHAT IS IT USED FOR?
Aspirin Cardio inhibits the adhesion and clumping of blood platelets
(thrombocytes) and in this
way prevents blood clots (thrombi) from developing (inhibition of
platelet aggregation).
ASPIRIN CARDIO IS USED FOR:
-
Unstable angina pectoris (chest pain due to impaired circulation in
the coronary heart vessels)
– as part of the standard treatment;
-
Acute myocardial infarction – as part of the standard treatment;
-
Prevention of a repeat myocardial infarction after an initial
myocardial infarction (reinfarction
prophylaxis);
-
Following surgery or other interventions in arterial blood vessels
(e.g. after an aortocoronary
venous bypass [ACVB], in percutaneous transluminal coronary
angioplasty [PTCA]);
-
Prevention of transient ischaemic attacks (TIA) and cerebral
infarction following
manifestation of the precursor stages (e.g. transient signs o